While waiting for the EMA to be pronounced today, in Italy the most prudent stance on the matter involving the AstraZeneca vaccine was taken by the Italian Society for the study of haemostasis and thrombosis (Siset). And that is, one of the bodies most entitled to express itself on the possible correlation between the administration of the vaccine and the onset of the pathologies under investigation. Yesterday Siset, acknowledging “the alarm and anxiety produced in the population” by the suspension of vaccinations and the precautionary withdrawal of a batch, expressed in a note the recommendation that “all eligible subjects undergo vaccination against Covid-19 according to the vaccination plans prepared by the national and regional authorities “. As the Company did not fail to underline, the adverse event surveillance system set up by the EMA recorded, as of March 10, 30 cases of thrombotic events in 5 million subjects vaccinated with the AstraZeneca vaccine. A number “comparable to the thrombosis rate usually recorded in the general population.
At the moment it is not possible to establish whether there was a causal link between vaccination and thrombotic events or whether the events occurred only by coincidence ”. For this reason, “even taking into account that Covid-19 infection in a clinically significant form is associated with a significant increase in thrombotic risk, Siset believes that with the data currently available, the benefits of vaccination clearly outweigh the potential risks”. Which is a bit like saying that thrombosis sufferers should worry much more about the risk of contracting the virus than about any adverse reactions. An analysis so lucid that a question arises spontaneously: but instead of running with a scandalistic air towards the prosecutors, uncritically marrying the investigative line, the newspapers could not limit themselves to giving a voice to those who deal with these issues by profession?